Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holten-Andersen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Biology & Therapy|January 17, 2004
Identification of novel survivin-derived CTL epitopesSine Reker, Anders Meier, Lars Holten-Andersen, et al.
Scandinavian Journal of Gastroenterology|August 9, 2012
Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective studyLars Holten-Andersen, Ib Jarle Christensen, Siri Beier Jensen, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2004
Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patientsAnders Meier, Sine Reker, Inge Marie Svane, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 15, 2011
Salivary tissue inhibitor of metalloproteinases-1 localization and glycosylation profile analysisLars Holten-Andersen, Morten Thaysen-Andersen, Siri Beier Jensen, et al.
Plos One|November 13, 2012
Approaches towards DNA vaccination against a skin ciliate parasite in fishLouise von Gersdorff Jørgensen, Jens Sigh, Per Walter Kania, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 11, 2019
Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for HypoparathyroidismLars Holten-Andersen, Susanne Pihl, Caroline E Rasmussen, et al.
Blood Advances|January 22, 2026
HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand DiseaseMattias Häger, Minka Zivkovic, Prafull S Gandhi, et al.
Cancer Cell International|September 19, 2022
Intratumoral delivery of TransCon<sup>™</sup> TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine inductionLuis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Biology & Therapy|January 17, 2004
Identification of novel survivin-derived CTL epitopesSine Reker, Anders Meier, Lars Holten-Andersen, et al.
Scandinavian Journal of Gastroenterology|August 9, 2012
Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective studyLars Holten-Andersen, Ib Jarle Christensen, Siri Beier Jensen, et al.
Cancer Immunology, Immunotherapy : CII|December 8, 2004
Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patientsAnders Meier, Sine Reker, Inge Marie Svane, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|October 15, 2011
Salivary tissue inhibitor of metalloproteinases-1 localization and glycosylation profile analysisLars Holten-Andersen, Morten Thaysen-Andersen, Siri Beier Jensen, et al.
Plos One|November 13, 2012
Approaches towards DNA vaccination against a skin ciliate parasite in fishLouise von Gersdorff Jørgensen, Jens Sigh, Per Walter Kania, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 11, 2019
Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for HypoparathyroidismLars Holten-Andersen, Susanne Pihl, Caroline E Rasmussen, et al.
Blood Advances|January 22, 2026
HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand DiseaseMattias Häger, Minka Zivkovic, Prafull S Gandhi, et al.
Cancer Cell International|September 19, 2022
Intratumoral delivery of TransCon<sup>™</sup> TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine inductionLuis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, et al.
Pageof 2